Estados financieros detallados de Artelo Biosciences, Inc. (ARTL): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Márgenes de los últimos 12 meses: margen bruto 0.0%, margen operativo 0.0%, margen neto 0.0%.
Al precio actual de $3.75, ARTL presenta beneficios negativos (P/E no significativo) y un ROE del -5.19%. La capitalización bursátil es de $1M.
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Ingresos | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Coste de Ventas | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Bruto | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| I+D | 0 | 0 | $1.2M | $1.1M | $1.9M | $2.8M | $4.3M | $5.7M | $6.0M | $5.4M |
| Generales y Administrativos | $29690 | $232789 | $1.1M | $2.1M | $2.8M | $4.6M | $6.0M | $4.2M | $4.1M | $6.0M |
| Gastos Operativos | $29690 | $232789 | $2.3M | $3.2M | $4.7M | $7.4M | $10.3M | $9.9M | $10.1M | $11.4M |
| Beneficio Operativo | -$29690 | -$232789 | -$2.3M | -$3.2M | -$4.7M | -$7.4M | -$10.3M | -$9.9M | -$10.1M | -$11.4M |
| EBITDA | -$29690 | -$232789 | -$2.3M | -$4.2M | -$4.7M | -$7.4M | -$10.1M | -$9.3M | -$9.8M | -$12.5M |
| Gastos por Intereses | 0 | $2100 | 0 | 0 | 0 | 0 | $5000 | 0 | 0 | $194000 |
| Beneficio Antes de Impuestos | -$29690 | -$234889 | -$2.3M | -$2.2M | -$4.7M | -$7.4M | -$10.1M | -$9.3M | -$9.8M | -$12.9M |
| Impuestos | 0 | 0 | $8 | -$2.0M | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Neto | -$29690 | -$234889 | -$2.3M | -$2.2M | -$4.7M | -$7.4M | -$10.1M | -$9.3M | -$9.8M | -$12.9M |
| BPA | $-1.41 | $-9.69 | $-82.55 | $-45.00 | $-56.48 | $-17.91 | $-10.47 | $-9.42 | $-9.15 | $-49.23 |
| BPA Diluido | $-1.41 | $-9.69 | $-82.55 | $-45.00 | $-56.48 | $-17.91 | $-10.47 | $-9.42 | $-9.15 | $-49.23 |
| Acciones en Circulación (Diluidas) | $3537 | $4043 | $4732 | $8046 | $13732 | $69166 | $157388 | $986667 | $1.1M | $261832 |
Cuenta de Resultados (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Ingresos | 0 | 0 | 0 | 0 |
| Beneficio Bruto | 0 | 0 | 0 | 0 |
| Beneficio Operativo | -$3.1M | -$2.8M | -$2.7M | -$2.5M |
| EBITDA | -$3.0M | -$3.8M | -$2.8M | -$2.4M |
| Beneficio Neto | -$3.1M | -$4.2M | -$3.0M | -$2.4M |
| BPA | $-11.91 | $-18.36 | $-36.00 | $-8.01 |
| BPA Diluido | $-11.91 | $-18.36 | $-36.00 | $-8.01 |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Caja y Equivalentes | $3590 | $572775 | $337424 | $4.4M | $2.1M | $6.6M | $6.9M | $2.8M | $2.3M | $600000 |
| Inversiones a Corto | 0 | 0 | 0 | 0 | 0 | $3.4M | $10.6M | $7.6M | 0 | 0 |
| Cuentas por Cobrar | 0 | 0 | $22127 | $8787 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventario | 0 | 0 | 0 | -$8787 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $3590 | $574275 | $396435 | $4.4M | $2.3M | $10.3M | $18.3M | $11.0M | $2.6M | $695000 |
| Inmovilizado Material | 0 | 0 | $563 | $721 | 0 | $90000 | $60000 | $21000 | $99000 | $64000 |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | $2.0M | $2.0M | $2.0M | $2.0M | $2.0M | $2.0M | $2.0M |
| Activos Totales | $3590 | $574275 | $396998 | $6.5M | $4.4M | $12.6M | $20.4M | $13.0M | $4.7M | $2.8M |
| Cuentas por Pagar | $12940 | $28576 | $529272 | $348863 | $489000 | $471000 | $905000 | $1.2M | $1.7M | $3.0M |
| Deuda a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $609000 |
| Pasivos Corrientes | $17390 | $29438 | $531972 | $1.0M | $501000 | $526000 | $998000 | $1.3M | $1.8M | $4.0M |
| Deuda a Largo | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Totales | $17390 | $29438 | $531972 | $1.0M | $501000 | $593000 | $1.0M | $1.3M | $1.8M | $4.1M |
| Reservas | -$60200 | -$295089 | -$2.6M | -$4.8M | -$9.5M | -$16.9M | -$31.0M | -$40.3M | -$50.1M | -$63.0M |
| Patrimonio Neto | -$13800 | $544837 | -$134974 | $5.5M | $3.9M | $12.0M | $19.4M | $11.8M | $2.9M | -$1.3M |
| Deuda Total | 0 | 0 | 0 | 0 | 0 | $95000 | $63000 | $23000 | $104000 | $678000 |
| Deuda Neta | -$3590 | -$572775 | -$337424 | -$4.4M | -$2.1M | -$10.0M | -$17.5M | -$10.4M | -$2.2M | $78000 |
| Capital Circulante | -$13800 | $544837 | -$135537 | $3.4M | $1.8M | $9.8M | $17.3M | $9.7M | $785000 | -$3.3M |
Balance (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Caja y Equivalentes | $1.7M | $600000 | $10.3M | $4.2M |
| Activos Totales | $4.3M | $2.8M | $12.5M | $6.5M |
| Pasivos Totales | $4.9M | $4.1M | $5.8M | $1.5M |
| Patrimonio Neto | -$633000 | -$1.3M | $6.7M | $5.0M |
| Deuda Total | $954000 | $678000 | $719000 | $49000 |
Flujo de Caja (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Beneficio Neto | -$29690 | -$234889 | -$2.3M | -$2.2M | -$4.7M | -$7.4M | -$10.1M | -$9.3M | -$9.8M | -$12.9M |
| Amortizaciones | 0 | $600 | $282 | $510 | $500 | 0 | 0 | 0 | 0 | $146000 |
| Compensación en Acciones | 0 | $3332 | $290004 | $425110 | $381000 | $1.5M | $2.5M | $1.0M | $818000 | $1.1M |
| Cambio en Capital Circulante | $11201 | $14136 | $443185 | -$140021 | -$43000 | -$242000 | -$172000 | $703000 | $937000 | $1.8M |
| Flujo de Caja Operativo | -$18489 | -$216821 | -$1.6M | -$2.8M | -$4.3M | -$6.1M | -$8.0M | -$8.2M | -$8.3M | -$8.5M |
| Inversiones (CapEx) | 0 | 0 | -$845 | -$1.5M | 0 | 0 | 0 | 0 | 0 | 0 |
| Adquisiciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Recompra de Acciones | 0 | 0 | 0 | 0 | -$108 | 0 | 0 | 0 | 0 | 0 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$18489 | -$216821 | -$1.6M | -$4.3M | -$4.3M | -$6.1M | -$8.0M | -$8.2M | -$8.3M | -$8.5M |
Flujo de Caja (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Flujo de Caja Operativo | -$3.5M | -$2.9M | -$1.2M | -$5.0M |
| Inversiones (CapEx) | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$3.5M | -$2.9M | -$1.2M | -$5.0M |
| Dividendos Pagados | 0 | 0 | 0 | 0 |
| Compensación en Acciones | $432000 | $368000 | $401000 | $570000 |
Crecimiento y Márgenes (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Crecimiento Beneficio Neto (anual) | | -691.1% | -897.7% | +7.3% | -114.3% | -59.8% | -35.6% | +7.9% | -5.8% | -31.1% |
| Crecimiento BPA (anual) | | -587.2% | -752.0% | +45.5% | -25.5% | +68.3% | +41.5% | +10.0% | +2.9% | -438.1% |
| Cambio en Acciones (anual) | | +14.3% | +17.0% | +70.0% | +70.7% | +403.7% | +127.6% | +526.9% | +8.9% | -75.6% |
| Crecimiento FCF (anual) | | -1072.7% | -642.9% | -166.5% | -1.2% | -41.3% | -30.4% | -2.5% | -1.7% | -2.0% |
| Tasa Impositiva Efectiva | -0.0% | -0.0% | -0.0% | 94.1% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% |
Datos por Acción (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| FCF por Acción | $-5.23 | $-53.63 | $-340.42 | $-533.60 | $-316.56 | $-88.79 | $-50.88 | $-8.32 | $-7.77 | $-32.54 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $3500 | $4000 | $4667 | $8000 | $13722 | $69166 | $157333 | $986667 | $1.1M | $261832 |
Qué mirar en Biotech
La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.
- Cash Runway — Meses de caja al ritmo de gasto actual. <18 meses = riesgo de dilución urgente
- Cash burn anual — Ritmo al que queman caja operativa. Comparar con posición de caja para proyectar runway
- Total Debt — Biotech sin ingresos + deuda = receta para bancarrota
- I+D / Capitalización — Cuánto invierten en pipeline vs lo que vale la empresa — indicador de intensidad investigadora
- Market cap / Cash — Si cotiza cerca de su caja, el mercado le da ~0 valor al pipeline — puede ser oportunidad o trampa
Rentabilidad
| Rentabilidad sobre capital | -519.09% |
| Rentabilidad sobre capital invertido | -219.36% |
| Rentabilidad sobre activos | -196.18% |
| Margen bruto | 0.00% |
| Margen operativo | 0.00% |
| Margen neto | 0.00% |
Salud financiera
| Deuda / Patrimonio | 0.01 |
| Ratio corriente | 3.00 |
| Piotroski F-Score | 2 |
| Altman Z-Score | -45.94 |
Ratios Clave (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| P/E | -2671.54 | -388.74 | -45.63 | -35.10 | -13.77 | -41.22 | -14.91 | -8.03 | -6.26 | -0.22 |
| P/VC | -955.27 | 27.65 | -130.23 | 2.31 | 2.75 | 4.24 | 1.27 | 6.35 | 21.52 | -2.26 |
| P/V | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Margen Bruto | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Margen Operativo | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Margen Neto | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |